SBWire

Global Markets Direct's, 'Lysosomal Storage Disorder - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Lysosomal Storage Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Lysosomal Storage Disorder. Lysosomal Storage Disorder - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Market Direct's pharmaceuticals report, "Poxel SA - Product Pipeline Review - 2012" provides data on the Poxel SA's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

BMI maintains its broadly positive outlook of the Chilean freight transport sector for Q412. We caution, however, that volume growth is expected to slow, in line with our view that the Chilean economy's robust economic growth is likely to continue cooling in the coming quarters. We believe that declining exports, combined with a moderation of private consumption and gross fixed investment, will weigh on Chile's headline growth in 2012 and put pressure on the country's freight volumes. While we expect the Chilean economy to expand by a solid 4.8% in 2012, we do not believe growth will return to the 5.0% level any time soon. High labour costs, a moderation in external demand and a fiscally conservative government all point to a moderate 4.2% average growth rate over the next five years.

Australia's auto industry presents a decidedly mixed picture as we enter the final quarter of 2012. On the one hand, new car sales remain strong, with the country on course to post a record figure for the year. However, the outlook for domestic auto production is becoming clouded, with Australian consumers turning away from locally-produced larger sedan models towards cheaper, more fuel-efficient imports. Domestic production was up by just 2.8% over the first eight months of 2012.

From 2012 to 2016 the metals industry in China will be facing a period of steady declines in demand and supply growth. On the demand side, we are expecting a sharp slowdown in Chinese fixed asset investment that will see a softening in demand across metals. We expect construction activity in China to moderate significantly in 2012 and 2013, despite a temporary boost from infrastructure stimulus packages. The boom years of Chinese investment-led growth are over and this will seriously undermine growth of China's metals industry, particularly steel and aluminium.

Solar PV in Japan, Market Outlook to 2025 - Capacity, Generation, Levelized Cost of Energy (LCOE), Investment Trends, Regulations and Company Profiles is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the solar PV market in Japan. The report provides in depth analysis on global renewable power market and global solar PV market with forecasts up to 2025. The report analyzes the power market scenario in Japan (includes thermal conventional, nuclear, large hydro and renewables) and provides future outlook with forecasts up to 2025. The research details renewable power market outlook in the country (includes wind, small hydro, biopower and solar PV) and provides forecasts up to 2025. The report highlights installed capacity and power generation trends from 2001 to 2025 in Japan solar PV market. The research analyzes market segmentation by grid connectivity, investment trends and LCOE for solar PV in Japan during 2011-2025. The report provides information on the amount of carbon saved and average number of homes powered by solar PV during 2001-2025. A detailed coverage of renewable energy policy framework governing the market with specific policies pertaining to solar PV market development is provided in the report. The research also provides company snapshots of some of the major market participants.

This report examines the country's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the market's regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided.

GlobalData's clinical trial report, "Biliary Tract Disease Global Clinical Trials Review, H2, 2012" provides data on the Biliary Tract Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Biliary Tract Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Biliary Tract Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Our latest research provides key insights into how the wireless industry will form the foundation for the next electronics super cycle. At the forefront shall be next generation wireless devices that take advantage of embedded computing and machine to machine communications as well as consumer solutions involving wearable computing and next generation applications such as augmented reality.

Canada's mining sector will remain one of the steadiest growth stories in the Americas region thanks to diversified mineral deposits and a steady pipeline of investment. Canada mineral production is diversified across base and precious metals as well as industrial minerals. The country is a top ten global producer of zinc, lead, iron ore, nickel, copper, gold, silver, uranium and potash. With many companies both headquartered and producing in Canada, the mining sector is crucial to the Canadian economy. Thus, we expect Canada's political leadership to maintain favourable tax and regulatory policies for the sector. However, weak US growth, eurozone troubles, and slowing, less commodity-intensive growth in China, will lead to slow, albeit stable growth in the Canadian mining sector.

GlobalData's clinical trial report, "Venous Leg Ulcers (Crural ulcer) Global Clinical Trials Review, H2, 2012" provides data on the Venous Leg Ulcers (Crural ulcer) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Leg Ulcers (Crural ulcer). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Venous Leg Ulcers (Crural ulcer). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's new report, "South Africa Diagnostic Imaging Market Outlook to 2018 - Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others" provides key market data on the South Africa Diagnostic Imaging market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 10 market categories - Angio Suites, Bone Densitometers, C-Arms, Computed Tomography Systems, Contrast Media Injectors, Mammography Equipment, MRI Systems, Nuclear Imaging Equipment, Ultrasound Systems and X-ray Systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

GlobalData's new report, "X-Ray Systems Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018" provides key market data on the X-Ray Systems market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment within three market categories -Digital X-ray Systems, Analog X-ray Systems and Retrofit X-ray Systems. The report also provides company shares and distribution shares data for the overall X-Ray Systems market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

GlobalData's report, "Heat Recovery Steam Generators (HRSGs) for Thermal Power, 2012 - Global Market Size, Market Share, Average Pricing and Trends to 2020" gives detailed information on the key national HRSG equipment markets. Sales volumes, revenue forecasts, average pricing, market share analysis and key trends are covered for the global HRSG market. The report covers eight countries including the US, Mexico, Spain, the UK, Iran, China, India and Indonesia which are key to the global HRSG market. Sales volumes, revenue forecasts, average pricing, market share analysis, drivers and restraints are covered for these countries.

The global hyperparathyroidism therapeutics market is forecast to grow to reach $2.6 billion by 2019. This moderate growth is primarily attributed to the increase in the hyperparathyroidism patient population and the expected launches of two novel drugs: CTAP101 and KAI-4169 IV. The major barriers for the hyperparathyroidism therapeutics market during forecast period are the introduction of bundled dialysis payment system in the US and the expected patent expirations of all three leading branded drugs in the market: Sensipar/Mimpara, Zemplar and Hectorol. The hyperparathyroidism pipeline is weak, with only seven molecules in various stages of development, including four first-in-class molecules and three me-too products. Amgen and Abbott are the leading companies in the current competitive landscape. Amgen is likely to maintain its position during the forecast period due to its acquisition in July 2012 of KAI Pharmaceuticals and its promising pipeline molecule KAI-4169.

GlobalData's clinical trial report, "Gastroenteritis Global Clinical Trials Review, H2, 2012" provides data on the Gastroenteritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Gastroenteritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Gastroenteritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in United Arab Emirates. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the natural gas assets (gas fields, pipelines and LNG terminals) in United Arab Emirates. The report compares the investment environment in United Arab Emirates with other countries in the region. The profiles of the major companies operating in the natural gas sector in United Arab Emirates together with the latest news and deals are also included in the report.

"Marine Power (Wave and Tidal) - Installed Capacity, Levelized Cost of Energy (LCOE), Profiles of Technology Developers and Key Country Analysis to 2030" is the latest report from GlobalData, the industry analysis specialists that offer comprehensive information and understanding of the marine energy industry. The report provides clear understanding of the global marine power market. The report provides an overview of various marine energy technologies such as wave energy, tidal energy, ocean thermal energy and energy from salinity gradient. The report covers information on requirements for development of a marine energy project and information on distribution of marine projects (wave and tidal) across various major countries. Further, the report covers cost break-up for wave and tidal projects, profiles of major technology providers and installed capacity forecasts to 2030. Countries covered in the report include the US, Canada, the UK, Portugal, Republic of Korea and Australia. Information such as technology potential, power projects in demonstration and development stage and policy support for the industry is covered in detail. Companies covered in the report include Ocean Renewable Power Company, Aquamarine Power, AWS Ocean Energy, Carnegie Wave Energy Limited, Marine Current Turbines Limited, Ocean Power Technologies, Oceanlinx Limited, OpenHydro Group Limited, Pelamis Wave Power, Pulse Tidal, Verdant Power, Voith Hydro Wavegen Limited, BioPower Systems Pty, Tidal Generation Limited, Wavebob and Wello OY.

This report examines the country's power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. Detailed analysis of the market's regulatory structure, import and export trends, competitive landscape and power projects at various stages of the supply chain is provided. This report also includes a detailed analysis of the country's power sector across 6 broad parameters. Each parameter has a weight assigned, and a weighted average score is calculated to obtain the final country ranking in that region.

GlobalData's new report, "New Zealand Healthcare IT Market Outlook to 2018 - Clinical IT Systems and Medical Imaging Information Systems" provides key market data on the New Zealand Healthcare IT market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Clinical IT Systems and Medical Imaging Information Systems. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

GlobalData's report, Acetone Industry Outlook in Korea to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of Korea Acetone industry. The research presents major market trends affecting the Acetone industry in Korea. The report covers Korea Acetone plants and presents installed capacity by process and technology. In addition, it presents Acetone demand and production forecasts, end use demand forecasts, price trends, trade balance data and company shares of the major Acetone producers in Korea. Overall, the report presents a comprehensive coverage of Korea Acetone industry including all the major parameters.

GlobalData's report, Caprolactam Industry Outlook in Mexico to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of Mexico Caprolactam industry. The research presents major market trends affecting the Caprolactam industry in Mexico. The report covers Mexico Caprolactam plants and presents installed capacity by process and technology. In addition, it presents Caprolactam demand and production forecasts, end use demand forecasts, price trends, trade balance data and company shares of the major Caprolactam producers in Mexico. Overall, the report presents a comprehensive coverage of Mexico Caprolactam industry including all the major parameters

Global Markets Direct's, 'Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Congestive Heart Failure (Heart Failure), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Congestive Heart Failure (Heart Failure). Congestive Heart Failure (Heart Failure) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

The MamaBear child tracking app has expanded to include Instagram alerts as part of the recent upgrade to the 1.2.8 software. These new Instagram alert options give parents a deeper look into a child's social media interactions. In addition to monitoring Facebook tags, posts, photos, friends and restricted words, MamaBear now offers alerts related to Instagram. As with Facebook, the parent can easily login to the child’s Instagram account on the parental version of the app. Once the Instagram account has been added the parent is given Instagram monitoring options in the social media alerts menu. Parents can receive alerts via email or push notifications on any internet enabled Apple Device running iOS 4 or better or any Android device.

Some of the factors driving neurometabolic disorders market are rising incidences of neurometabolic disorders and growing ageing population. Launch of new drugs coupled with the rising awareness among patients and physicians are expected to increase revenues for the neurometabolic disorders industry in the coming years.Government agencies and private companies are taking extra measures to increase awareness among patients and physicians regarding diseases and their available treatment options. Enzyme replacement therapy (ERT) is currently the available therapeutic option for most neurometabolic diseases.